Vanguard Group’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,139,600
| Closed | -$143M | – | 4255 |
|
|
2020
Q3 | $143M | Sell |
4,139,600
-62,944
| -1% | -$2.17M | ﹤0.01% | 1489 |
|
|
2020
Q2 | $70.2M | Buy |
4,202,544
+65,198
| +2% | +$1.09M | ﹤0.01% | 1837 |
|
|
2020
Q1 | $59.7M | Buy |
4,137,346
+96,511
| +2% | +$1.39M | ﹤0.01% | 1783 |
|
|
2019
Q4 | $135M | Buy |
4,040,835
+287,135
| +8% | +$9.61M | ﹤0.01% | 1602 |
|
|
2019
Q3 | $78.6M | Buy |
3,753,700
+47,306
| +1% | +$991K | ﹤0.01% | 1851 |
|
|
2019
Q2 | $77.2M | Buy |
3,706,394
+164,038
| +5% | +$3.42M | ﹤0.01% | 1887 |
|
|
2019
Q1 | $79.2M | Sell |
3,542,356
-132,718
| -4% | -$2.97M | ﹤0.01% | 1859 |
|
|
2018
Q4 | $87.9M | Buy |
3,675,074
+95,768
| +3% | +$2.29M | ﹤0.01% | 1743 |
|
|
2018
Q3 | $97.6M | Buy |
3,579,306
+135,159
| +4% | +$3.69M | ﹤0.01% | 1816 |
|
|
2018
Q2 | $92.6M | Buy |
3,444,147
+136,149
| +4% | +$3.66M | ﹤0.01% | 1820 |
|
|
2018
Q1 | $105M | Buy |
3,307,998
+721,726
| +28% | +$23M | ﹤0.01% | 1687 |
|
|
2017
Q4 | $97.8M | Sell |
2,586,272
-36,748
| -1% | -$1.39M | ﹤0.01% | 1738 |
|
|
2017
Q3 | $65M | Buy |
2,623,020
+146,184
| +6% | +$3.62M | ﹤0.01% | 1923 |
|
|
2017
Q2 | $50.9M | Buy |
2,476,836
+276,978
| +13% | +$5.69M | ﹤0.01% | 2009 |
|
|
2017
Q1 | $47.8M | Buy |
2,199,858
+513,803
| +30% | +$11.2M | ﹤0.01% | 2033 |
|
|
2016
Q4 | $34.5M | Buy |
1,686,055
+165,487
| +11% | +$3.38M | ﹤0.01% | 2150 |
|
|
2016
Q3 | $22.8M | Buy |
1,520,568
+180,721
| +13% | +$2.71M | ﹤0.01% | 2308 |
|
|
2016
Q2 | $14.5M | Buy |
1,339,847
+109,457
| +9% | +$1.18M | ﹤0.01% | 2470 |
|
|
2016
Q1 | $16.7M | Buy |
1,230,390
+533,582
| +77% | +$7.24M | ﹤0.01% | 2374 |
|
|
2015
Q4 | $12.9M | Buy |
696,808
+133,884
| +24% | +$2.47M | ﹤0.01% | 2497 |
|
|
2015
Q3 | $14.3M | Buy |
+562,924
| New | +$14.3M | ﹤0.01% | 2432 |
|